684 related articles for article (PubMed ID: 20853577)
1. Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells.
Meng RQ; Hackfeld LC; Hedge RP; Wisse LA; Redetzke DL; Walker VE;
Res Rep Health Eff Inst; 2010 Jun; (150):1-34; discussion 35-41. PubMed ID: 20853577
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
3. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
4. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
5. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of stereochemical configurations of 1,2-epoxybutene and 1,2:3,4-diepoxybutane in human lymphblastoid cells.
Meng Q; Redetzke DL; Hackfeld LC; Hodge RP; Walker DM; Walker VE
Chem Biol Interact; 2007 Mar; 166(1-3):207-18. PubMed ID: 16854403
[TBL] [Abstract][Full Text] [Related]
7. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
[TBL] [Abstract][Full Text] [Related]
8. Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol.
Powley MW; Li Y; Upton PB; Walker VE; Swenberg JA
Carcinogenesis; 2005 Sep; 26(9):1573-80. PubMed ID: 15888494
[TBL] [Abstract][Full Text] [Related]
9. Age-, gender-, and species-dependent mutagenicity in T cells of mice and rats exposed by inhalation to 1,3-butadiene.
Meng Q; Walker DM; McDonald JD; Henderson RF; Carter MM; Cook DL; McCash CL; Torres SM; Bauer MJ; Seilkop SK; Upton PB; Georgieva NI; Boysen G; Swenberg JA; Walker VE
Chem Biol Interact; 2007 Mar; 166(1-3):121-31. PubMed ID: 16945358
[TBL] [Abstract][Full Text] [Related]
10. Persistence of N7-(2,3,4-trihydroxybutyl)guanine adducts in the livers of mice and rats exposed to 1,3-butadiene.
Oe T; Kambouris SJ; Walker VE; Meng Q; Recio L; Wherli S; Chaudhary AK; Blair IA
Chem Res Toxicol; 1999 Mar; 12(3):247-57. PubMed ID: 10077487
[TBL] [Abstract][Full Text] [Related]
11. Mutagenicity of the racemic mixtures of butadiene monoepoxide and butadiene diepoxide at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats.
Meng Q; Henderson RF; Walker DM; Bauer MJ; Reilly AA; Walker VE
Mutat Res; 1999 Aug; 429(1):127-40. PubMed ID: 10434028
[TBL] [Abstract][Full Text] [Related]
12. The importance of 3,4-epoxy-1,2-butanediol and hydroxymethylvinyl ketone in 3-butene-1,2-diol associated mutagenicity.
Powley MW; Walker VE; Li Y; Upton PB; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):182-90. PubMed ID: 17349618
[TBL] [Abstract][Full Text] [Related]
13. Measurement of plasma or urinary metabolites and Hprt mutant frequencies following inhalation exposure of mice and rats to 3-butene-1,2-diol.
Walker DM; McDonald JD; Meng Q; Kracko DA; Bauer MJ; Seilkop SK; Walker EL; Henderson RF; Walker VE
Chem Biol Interact; 2007 Mar; 166(1-3):191-206. PubMed ID: 17316587
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study.
Albertini RJ; Srám RJ; Vacek PM; Lynch J; Nicklas JA; van Sittert NJ; Boogaard PJ; Henderson RF; Swenberg JA; Tates AD; Ward JB; Wright M; Ammenheuser MM; Binkova B; Blackwell W; de Zwart FA; Krako D; Krone J; Megens H; Musilová P; Rajská G; Ranasinghe A; Rosenblatt JI; Rössner P; Rubes J; Sullivan L; Upton P; Zwinderman AH
Res Rep Health Eff Inst; 2003 Jun; (116):1-141; discussion 143-62. PubMed ID: 12931846
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
Albertini RJ; Sram RJ; Vacek PM; Lynch J; Rossner P; Nicklas JA; McDonald JD; Boysen G; Georgieva N; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):63-77. PubMed ID: 16949064
[TBL] [Abstract][Full Text] [Related]
16. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
Recio L; Steen AM; Pluta LJ; Meyer KG; Saranko CJ
Chem Biol Interact; 2001 Jun; 135-136():325-41. PubMed ID: 11397399
[TBL] [Abstract][Full Text] [Related]
17. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
Carcinogenesis; 1995 Aug; 16(8):1723-31. PubMed ID: 7634396
[TBL] [Abstract][Full Text] [Related]
18. Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine.
Wood AW; Chang RL; Levin W; Kumar S; Shirai N; Jerina DM; Lehr RE; Conney AH
Cancer Res; 1986 Jun; 46(6):2760-6. PubMed ID: 3516386
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of hprt mutant lymphocytes from 1, 3-butadiene-exposed workers.
Ma H; Wood TG; Ammenheuser MM; Rosenblatt JI; Ward JB
Environ Mol Mutagen; 2000; 36(1):59-71. PubMed ID: 10918361
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
Meng Q; Su T; O'Neill JP; Walker VE
Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
